<DOC>
	<DOC>NCT00317226</DOC>
	<brief_summary>The primary objective of this study is to evaluate the long term safety and tolerability of an iron maintenance dosing strategy utilizing VIT45 in the treatment of anemia of non-dialysis dependent chronic kidney disease (NDD-CKD). This study is a long term extension to protocol 1VIT04004 (NCT00317239).</brief_summary>
	<brief_title>Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease</brief_title>
	<detailed_description>The primary objective of this study is to evaluate the long term safety and tolerability of an iron maintenance dosing strategy utilizing VIT45 in the treatment of anemia of non-dialysis dependent chronic kidney disease (NDD-CKD). This study is a long term extension to protocol 1VIT04004. In this study patients that complete protocol 1VIT 04004 or are discontinued will be offered to participate in this extension study.</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Subjects who completed or discontinued Protocol 1VIT04004 Known hypersensitivity reaction to VIT45 Anemia not related to CKD Chronic, serious infection Recent IV iron other than study drug in past 12 weeks Recent blood loss within the last 12 weeks Need for surgery or dialysis Female subjects who are pregnant or lactating</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Anemia</keyword>
	<keyword>CKD</keyword>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Iron</keyword>
	<keyword>Maintenance Dose</keyword>
</DOC>